we conclude that the CHADS2 and CHA2DS-VASc sore are associated with adverse vascular function and predict new-onset ischemic stroke, MI, CV death and combined CV endpoints including CHF in high-risk CV patient without AF.Incorporating PR prolongation to the CHADS2 score resulted in further increased prediction for new-onset CV events. Such finding need to be further independently validate in other large-scaled study population.